New Stroke Treatment Shows Promise for Patients With Medium-Vessel Blockages
A major new study from China suggests that a specialized procedure called endovascular thrombectomy can significantly improve recovery for certain stroke patients. The research, known as the ORIENTAL-MeVO trial, focused on people who had moderate-to-severe strokes caused by blockages in medium-sized blood vessels in the brain.
For decades, doctors have used clot-busting drugs and, more recently, mechanical clot removal for large-vessel strokes. But the best approach for medium-vessel occlusions has been less clear. This new evidence provides fresh guidance for doctors and hope for patients and their families.
What the Study Found
The study, published in the New England Journal of Medicine, included 563 adults treated at 48 medical centers across China. All patients had experienced a moderate-to-severe stroke within the previous 24 hours. Their average age was 71 years, and about 43% were women.
Researchers randomly assigned patients to one of two groups. One group received standard medical care alone. The other group received standard medical care plus endovascular thrombectomy, a procedure where doctors thread a thin tube through an artery in the groin or wrist up to the brain to physically remove the clot.
The results were striking. Patients who had the clot removal procedure were 24% more likely to survive with no more than mild disability after 90 days. Specifically, 58.6% of thrombectomy patients achieved this good outcome, compared with 46.6% of those who received only medical treatment.
Statistically, this difference was highly significant. The researchers calculated that for every 8.2 patients treated with thrombectomy, one additional patient would achieve functional independence. This number, called the “number needed to treat,” is similar to what doctors see with established stroke treatments.
Risks and Safety Concerns
No medical procedure is without risks. The study found that patients who underwent thrombectomy had a slightly higher rate of symptomatic intracranial hemorrhage — bleeding in the brain that causes symptoms. This occurred in 4.7% of the thrombectomy group compared with 2.2% of the medical-only group. However, this difference was not statistically significant, meaning it could have been due to chance.
Similarly, 90-day mortality rates were 11.1% in the thrombectomy group and 10.2% in the medical group. Again, this difference was not statistically significant.
These numbers highlight an important reality: while thrombectomy can help many patients, it does not help everyone, and some patients may be harmed. This is why careful patient selection is critical.
Who Is Most Likely to Benefit?
The study authors emphasized that patient selection matters enormously. Not every patient with a medium-vessel occlusion will benefit from clot removal. In fact, two earlier trials — ESCAPE-MeVO and DISTAL — found neutral results, meaning thrombectomy did not improve outcomes for the average patient with medium-vessel stroke.
So what made ORIENTAL-MeVO different? The key was that this study focused on patients with more severe strokes. All participants had a National Institutes of Health Stroke Scale score of 6 or higher, with a median score of 10. This scale ranges from 0 to 42, with higher numbers indicating more severe stroke symptoms.
In an editorial accompanying the study, experts Dr. Johanna M. Ospel and Dr. Michael D. Hill from the University of Calgary explained that the ORIENTAL-MeVO trial provides evidence for a specific subset of patients: those who are younger, have more severe strokes, and are treated earlier after symptom onset.
“Most patients with stroke due to medium-vessel occlusion will not benefit from endovascular thrombectomy,” they cautioned. But for carefully selected patients, the procedure can be life-changing.
How This Affects You and Your Loved Ones
Stroke is a leading cause of disability worldwide. Every 40 seconds, someone in the United States has a stroke. For families, a stroke can mean sudden, life-altering changes in a loved one’s ability to speak, move, or care for themselves.
This study matters because it gives doctors more precise tools to decide who should get thrombectomy. For patients with moderate-to-severe strokes from medium-vessel blockages, this procedure could mean the difference between returning home independently and needing long-term nursing care.
However, it also reinforces that time is brain. The faster a patient gets to a hospital that can perform thrombectomy, the better their chances. In this study, the median time from stroke onset to the start of the clot removal procedure was just 5.3 hours.
What Experts Say About Treatment Selection
Dr. Wei Hu, the lead study author from the First Affiliated Hospital of the University of Science and Technology of China, noted that careful imaging is essential. Patients in the study were only included if brain scans showed that the area of the brain at risk was not already too damaged.
Specifically, eligible patients had less than 50% ischemic involvement of the at-risk brain territory on CT or MRI scans. Alternatively, they could have a “mismatch” pattern on perfusion imaging, where the area of brain at risk was significantly larger than the area already damaged.
The editorial authors stressed that “well-evolved infarcts” — areas of brain that have already died from lack of blood flow — are unlikely to benefit from reopening the vessel. In fact, reopening a vessel to an area of dead brain tissue can sometimes cause bleeding and harm.
They also suggested that patients who have not received clot-busting drugs (thrombolysis) may get greater benefit from mechanical thrombectomy. In this study, about 37% of patients received IV thrombolysis before the procedure.
Practical Takeaways for Patients and Families
If you or someone you know experiences stroke symptoms, here is what this research means for you:
- Recognize stroke symptoms FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911. Every minute counts.
- Go to a comprehensive stroke center: Not all hospitals can perform thrombectomy. Hospitals with specialized stroke teams and interventional radiologists are best equipped.
- Ask about thrombectomy: If a loved one has a moderate-to-severe stroke and imaging shows a medium-vessel blockage, ask the medical team whether thrombectomy is an option.
- Understand the risks: While thrombectomy improves outcomes for many, it carries a small risk of brain bleeding. Doctors will weigh the potential benefits against these risks.
- Know that not all strokes are the same: This study applies specifically to medium-vessel occlusions with moderate-to-severe deficits. Patients with milder strokes or different types of blockages may not benefit.
What Comes Next
The ORIENTAL-MeVO trial was conducted exclusively in China, where the rate of embolic stroke (stroke caused by clots traveling from elsewhere in the body) is lower than in Western populations. This may limit how directly the results apply to patients in the United States and Europe.
However, a similar trial called DUSK is currently underway in the U.S. to test thrombectomy for medium-vessel strokes. The results of that study will help confirm whether these findings hold true for American patients.
Researchers are also planning further studies to refine which patients benefit most. The editorial authors noted that “favorable baseline imaging” — meaning good collateral blood flow or a favorable mismatch profile — and faster treatment are likely to be important factors.
The Bottom Line
Endovascular thrombectomy can significantly improve outcomes for carefully selected patients with moderate-to-severe strokes caused by medium-vessel blockages. The procedure has risks, including a small chance of brain bleeding, but for the right patient, the benefits are substantial.
This study adds to a growing body of evidence that mechanical clot removal works not just for large-vessel strokes, but also for some medium-vessel strokes. The key is identifying which patients are likely to benefit — those with more severe deficits, favorable imaging, and early treatment times.
As always, prevention remains the best strategy. Managing blood pressure, controlling cholesterol, not smoking, staying physically active, and eating a heart-healthy diet can all reduce your risk of stroke. But if a stroke does occur, knowing the signs and getting to the right hospital quickly can save your life and your quality of life.
Source: MedPage Today
